(https://wellcome.org/grant-funding/schemes/discovery-awards)

Wellcome is soliciting applications for their Discovery Awards scheme from established researchers and teams from any discipline. Researchers who want to pursue bold and creative research ideas to deliver significant shifts in understanding that could improve human life, health and wellbeing are eligible to apply.  Successful applicants will be expected to actively promote a diverse, inclusive and supportive research environment within their team and across their organisation.  

Eligibility  

• Established Researchers 

Award details     

• Up to eight years and applicants may request a salary.    

Download the PDF outlining UCT’s deadlines for internal approval    

Funder deadline:  

Three deadlines annually, with the next one for 2026 being 31 March. 

(https://wellcome.org/research-funding/schemes/wellcome-career-development-awards)

Wellcome is soliciting applications for their Career Development Awards scheme. Mid-career researchers from any discipline who have the potential to be international research leaders are eligible to apply. Through this scheme they will develop their research capabilities, drive innovative programmes of work, and deliver significant shifts in understanding that could improve human life, health, and wellbeing. By the end of the award, successful candidates should have achieved international standing in their area of research.    

Eligibility  

• Mid-Career researchers  

Award details     

• Up to eight years and applicants may request a salary.    

Download the PDF outlining UCT’s deadlines for internal approval    

Funder deadline:  

Three deadlines annually, with the next one for 2026 being 26 March. 

(https://wellcomeleap.org/visible/)

Wellcome LEAP through its VISIBLE program (VISIBLE: Women’s heart disease revealed; access the full programme announcement here) is soliciting proposals across four thrust areas:

1. Develop scalable approaches for diagnosis and monitoring of coronary microvascular disease;
2. Identify risk factors and evaluate prognosis of coronary microvascular disease endotypes;
3. Build and validate multiscale, human-relevant models of the coronary microvasculature to interrogate causal mechanisms of coronary microvascular disease; and
4. Develop treatment strategies that improve both coronary microvascular function and patient-centred outcomes by testing existing therapies in well-characterized populations that most likely will benefit.

The goal of VISIBLE is to increase the proportion of women presenting with stable angina who receive effective diagnosis and treatment for coronary microvascular disease from <1% to >80%. In so doing, the program aims to demonstrate advances capable of reducing the burden of cardiovascular disease for millions of women worldwide.

All approaches must incorporate clinically deployable implementation strategies that expand effective care for coronary microvascular disease without increasing the risk of missed diagnosis or treatment of obstructive coronary heart disease.

Eligibility 

• Researchers with the skills, knowledge, and resources necessary to carry out the proposed research as the Principal Investigator.

Award details 

• Total Program Budget: US$55 million
• Individual Award Amount: Not preset; varies by proposal and is determined by project scope and review
• Funding Duration: Up to 3 years for selected projects under this program

Download the PDF outlining UCT’s deadlines for internal approval 

Funder deadline:

• Abstracts deadline: 09 March 2026
• Full proposal deadline: 23 April 2026

STEM MentHER UCT invites teachers and principals to nominate Grade 11 female learners who wish to pursue STEM (science, technology, engineering, and mathematics) careers. Successful learners will receive tailored mentorship and guidance from UCT academic mentors.

Nominations close: 31 March 2026.

Nomination link: https://forms.gle/a3kmx1iiLmKjhj369

Enquiries: lungile.sitole@uct.ac.za

(https://www.thempsfoundation.org/news-reviews-research/2026/01/22/mps-foundation-announces-new-research-grant-opportunities-for-2026)

The MPS Foundation, a leading not-for-profit research initiative dedicated to advancing patient safety and healthcare professional wellbeing, have announced the 2026 research grant application cycle.  The MPS Foundation seeks to support innovative research projects that have the potential to transform the future of healthcare.

This year, the Foundation is calling for Expressions of Interest from researchers and healthcare professionals interested in exploring the following key areas:

• The impact of human factors on patient safety, outcomes, and risk
• The personal and professional wellbeing of healthcare professionals and teams
• The impact of digital integration and technology on patient safety, outcomes, and risk
• Evaluation of the effectiveness of teaching and learning innovations.

Award details:  

• The MPS Foundation will consider:
• Proposals with a total budget of up to £60,000, which last between 3 and 24 months; and
• Proposals with a total budget of more than £60,000 and up to £200,000, which last between 12 and 36 months.
• Awardees will receive a maximum of £100,000 in any one year.

Eligibility:  

• Researchers with the skills, knowledge, and resources necessary to carry out the proposed research as the Principal Investigator

Download the PDF outlining UCT’s deadlines for internal approval 

Funder deadline:

Expressions of Interest due 1 May 2026

Dear FHS Colleagues and Students,

I am seeking 100 volunteers for my Master’s research study: "Validating Hair Ethyl Glucuronide (hEtG) as a Biomarker for Chronic Alcohol Misuse."

We are specifically looking for participants who meet the following criteria:

• Hair Type: Untreated (virgin) hair—no chemical relaxers, dyes, or bleach in the last 6 months.
• Hair Length: Minimum of 3 cm.

What is involved?
A brief 30-minute session at the Hair and Skin Research Lab at Groote Schuur Hospital for a small hair sample collection.

How to participate:
If you are interested, please contact hairetgstudy@gmail.com or sign up via the link

Read the Invitation to Participate here.

Several departments have indicated that they require assistance with the disposal of E-Waste. If your office or laboratory has any electronic or electrical devices no longer in use — including outdated computers, used batteries, or damaged printers — please complete the form via the link below.

Please note that photos of the E-Waste items must be attached to the form when submitting your request.

Complete the E-Waste Disposal Form

(https://childmind.org/global/snf-global-center/fellowships/research-fellowship/)

The SNF Global Center Research Fellowship is an extraordinary opportunity for early-career researchers at leading academic institutions in LMICs. This fellowship empowers innovative researchers committed to addressing local needs to advance the field of child and adolescent mental health. Fellows in the program serve as principal investigators of research projects that have the potential to transform mental health outcomes for young people in their countries and beyond.

• Award details:  
  Up to US$550,000 for a four-to-five-year project
   
  Eligibility:  
• Early-career researchers within 10 years of completing a doctoral degree
• Currently employed by an eligible host institution in a LMIC.
• Able to dedicate at least 50% of their full-time work to the Fellowship.
• Applicants must be nominated by an eligible institution in a LMIC.

NB:  Eligible institutions in LMICs may nominate up to two candidates for the 2026 cohort.
 
 

Funder webinar for nominating institutions: 12th March 2026, register here.    

Download the PDF outlining UCT’s deadlines for internal approval   

Funder deadline:  
The application for the 2026 SNF Global Center Research Fellowship will open in April 2026, with a deadline to apply of June 15, 2026

(https://wellcome.org/research-funding/schemes/establishing-infrastructure-hubs-power-evidence-synthesis) 

Wellcome will fund five new global infrastructure hubs to enable more timely, relevant and affordable AI-enabled evidence synthesis to address policy-scale challenges. This is part of Wellcome’s first series of Evidence Synthesis Infrastructure Collaborative (ESIC) investments.

The hubs will establish foundational evidence synthesis capabilities that can be used to address Wellcome’s strategic priorities in global health.  

Eligibility 

Established researchers with the skills, knowledge, and resources necessary to carry out the proposed research as the Principal Investigator.

Award details 

£1.5 to £1.9 million, for a period of 3-5 years

Download the PDF outlining UCT’s deadlines for internal approval  

Funder deadline: 

07 May 2026

The University of Cape Town Faculty of Health Sciences Equipment Committee (FEC) seeks to advance the research equipment infrastructure of the Faculty, aligned with the research strategies of the Faculty and Departments. The purpose of this scheme is to provide co-funding to research groups for single items of research equipment that do not qualify for equipment funding awards from the University Equipment Committee (UEC) or the Academic Computing Committee.

Eligibility:

·       Applicants must hold an academic or joint appointment in the UCT Faculty of Health Sciences and are limited to one application per round.

Award value:

·       The maximum award from the FEC is R100,000.

Funder deadline:

17 April 2026

Download full call and application form

(https://wellcome.org/research-funding/schemes/infectious-disease-clinical-trial-award-optimising-interventions-impact) 

Wellcome is pleased to share a new funding opportunity, Infectious Disease Clinical Trial Award: Optimising interventions for impact, delivered in partnership with the UK’s National Institute for Health and Care Research (NIHR). This funding call will support transdisciplinary teams led from Africa, South Asia or South-East Asia to conduct randomised controlled trials that optimise licensed pharmaceutical interventions for infectious diseases.

The clinical trial should generate evidence to inform changes to policy, practice and guidelines, and lead to measurable impact in the communities most affected, ultimately improving the treatment and prevention of infectious diseases in low- and middle-income countries.

The pharmaceutical intervention (vaccine or therapeutic) must focus on one of the following disease areas:

·       Mycobacterial infections (tuberculosis, leprosy or infections with non-tuberculous mycobacteria)

·       Bacterial infections (sexually transmitted infections, lower respiratory tract infections or bloodstream infections)

·       Invasive fungal infections

·       Dengue, leishmaniasis or schistosomiasis 

Eligibility 

The lead applicant must:

·       Be a mid-career or established researcher. If the lead applicant is a mid-career researcher, he/she needs to include an established researcher as a co-applicant to provide intellectual, personal and career development support and mentorship.

·       Be Based at an organisation in Africa, South Asia or South-East Asia (except mainland China) and intend to remain resident in that country for the duration of the award.

·       Have a permanent, open-ended or long-term rolling contract – or the guarantee of one – for the duration of the award.

Award details 

£1,000,000 - £8,000,000 per award, for a period of 3-5 years

Funder webinar, 23 March 2026 - registration link

Download the PDF outlining UCT’s deadlines for internal approval  

Funder deadline:

02 June 2026

(https://www.samrc.ac.za/funding/11th-gacd-multisectoral-approaches-call)

 The South African Medical Research Council (SAMRC) together with the Australian National Health and Medical Research Council (NHMRC) and the Canadian Institute of Health Research (CIHR), is inviting investigators to submit applications with a focus on implementation research, maximising collaboration and coordination with sectors and in settings beyond the healthcare system to tackle chronic non-communicable diseases in low- and middle-income countries and underserved populations in high-income countries (multisectoral approaches).

Eligibility 

·       Researchers with the skills, knowledge, and resources necessary to carry out the proposed research as the Principal Investigator.

·       One of the Principal Investigators (ideally the PI) must have a South African (SA) identity number (or permanent SA residence) and be a resident in SA for the duration of the project.

·       SAMRC requires joint funding from the NHMRC and/or CIHR.

o   Applicants intending to apply for joint funding from SAMRC & NHMRC should advise of their intent to participate in the call via email to international@nhmrc.gov.au.

o   Applicants intending to apply for joint funding from SAMRC & CIHR should advise of their intent to participate in the call via email to support-soutien@cihr-irsc.gc.ca and check CIHR agency-specific information.

·       Part of the project must take place in South Africa or on the African continent.

Award details 

·       SAMRC have a total budget of ~50,000 USD (~800,000 ZAR) per year and expects to jointly fund 1- 2 projects for 3-5 years.

Funder webinar, 24 March 2026- (10h00 registration link; 17h00 registration link)

Download the PDF outlining UCT’s deadlines for internal approval  

Funder deadline:

First stage proposal deadline: 17 June 2026